Oral Session 3-8A ATL: Clinical practice

[OS3-8A-1] A nationwide survey of adult T-cell leukemia-lymphoma (ATL) in Japan, 2012-2013

Shigeki Ito¹, Masako Iwanaga², Kisato Nosaka³, Kenji Ishitsuka⁴, Yoshitaka Imaizumi⁵, Kaoru Uchimaru⁶, Atae Utsunomiya⁷, Yoshiki Tokura⁸, Kensei Tobinai⁹, Kazuya Shimoda¹⁰, Sawako Nakachi¹¹, Toshiki Watanabe¹², Kunihiro Tsukasaki¹³ (1.Dept. of Clin Oncol., Iwate Medical University., Morioka, Japan, 2.Dept. of Frontier Life Science, Nagasaki University, Nagasaki, 3.Dept. of Hematology, Kumamoto University School of Medicine, Kumamoto, 4.Dept. of Hematology and Immunology, Kagoshima University Hospital, Kagoshima, 5.Dept. of Hematology, Nagasaki University Hospital, Nagasaki, 6.Laboratory of Tumor Cell Biology, The University of Tokyo, Tokyo, 7.Dept. of Hematology, Imamura General Hospital, Kagoshima, 8.Dept. of Dermatology, Hamamatsu University, Shizuoka, 9.National Cancer Centre Hospital, Tokyo, 10.Dept. of Gastroenterology and Hematology, University of Miyazaki, Miyazaki, 11.Second Dept. of Internal Medicine, University of Ryukyus Hospital, Okimawa, 12.Research Hospital, Institute of Medical Science, University of Tokyo, Tokyo, 13.Dept. of Hematology, International Medical Center, Saitama Medical University, Saitam)